Royal Bank of Canada’s Lunai Bioworks LNAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5K Buy
1,687
+1,646
+4,015% +$4.53K ﹤0.01% 6943
2026
Q1
$0 Buy
41
+35
+583% +$174 ﹤0.01% 7598
2025
Q4
$0 Sell
6
-12
-67% -$107 ﹤0.01% 7556
2025
Q3
$0 Buy
18
+6
+50% +$116 ﹤0.01% 7458
2025
Q2
$0 Sell
12
-96
-89% -$2.68K ﹤0.01% 7293
2025
Q1
$5K Buy
+108
New +$6.91K ﹤0.01% 6366
2024
Q4
Sell
-70
Closed -$2K 7191
2024
Q3
$2K Buy
70
+13
+23% +$901 ﹤0.01% 6658
2024
Q2
$8K Sell
57
-11
-16% -$1.5K ﹤0.01% 6423
2024
Q1
$14K Buy
+68
New +$18.3K ﹤0.01% 6073
2023
Q3
Sell
-9
Closed 7486
2023
Q2
$0 Sell
9
-12
-57% -$921 ﹤0.01% 7589
2023
Q1
$2K Sell
21
-20
-49% -$1.76K ﹤0.01% 6792
2022
Q4
$3K Buy
41
+38
+1,267% +$5.1K ﹤0.01% 6870
2022
Q3
$0 Buy
3
+2
+200% +$365 ﹤0.01% 7779
2022
Q2
$0 Sell
1
-19
-95% -$8.69K ﹤0.01% 7656
2022
Q1
$14K Buy
20
+15
+300% +$7.99K ﹤0.01% 6802
2021
Q4
$3K Buy
5
+4
+400% +$2.9K ﹤0.01% 7343
2021
Q3
$1K Sell
1
-54
-98% -$26.4K ﹤0.01% 7498
2021
Q2
$22K Buy
55
+41
+293% +$13.4K ﹤0.01% 6523
2021
Q1
$4K Hold
14
﹤0.01% 7110
2020
Q4
$3K Buy
+14
New +$3.54K ﹤0.01% 6806
2020
Q3
Hold
0
6887
2020
Q2
Sell
-17
Closed -$5.13K 6858
2020
Q1
$4K Buy
17
+7
+70% +$2.08K ﹤0.01% 6121
2019
Q4
$4K Buy
+10
New +$4.4K ﹤0.01% 6418

Other funds holding LNAI

Royal Bank of Canada's LNAI Position: Q2 2026 in Review

Royal Bank of Canada increased its Lunai Bioworks (LNAI) stake by 4,015% in Q2 2026, buying an estimated $4.53K and bringing the position to 1,687 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #6943.

Royal Bank of Canada first reported a position in LNAI in Q4 2019 and has held it in 22 quarters since. The position peaked at $22K in Q2 2021. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • Royal Bank of Canada held 1,687 shares of Lunai Bioworks worth $5K as of Q2 2026.
  • Royal Bank of Canada bought 1,646 Lunai Bioworks shares in Q2 2026, an estimated $4.53K.
  • Lunai Bioworks made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6943 holding.
  • Royal Bank of Canada first reported a position in Lunai Bioworks in Q4 2019 and has held it in 22 quarters since.
  • Royal Bank of Canada's Lunai Bioworks position peaked at $22K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.